Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 302

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 302
---
 any Governmental Authority, on the other hand, concerning or in connection with the Transactions; •the Business Combination Agreement also contains additional covenants and agreements among the parties thereto in respect of, among other matters: (a)jointly preparing, filing and distributing this proxy statement/prospectus on Form F -4(including any amendments or supplements thereto); (b)duly calling and giving notice of, and convening and holding the SPAC Shareholders’ Meeting for the purpose of obtaining SPAC Shareholders’ Approval; (c)support of the business combination transaction from the Company, SPAC and Merger Sub; (d)tax matters, including with respect to the intended Tax treatment; (e)reasonably cooperating, providing and access to information; (f)indemnification of present and former directors and officers of the Company, SPAC and each of their Subsidiaries; (g)maintaining in effect liability insurances covering those persons who are currently covered by directors’ and officers’ liability insurance policies of the Company, SPAC and each of their Subsidiaries; (h)litigation matters with respect to the Business Combination; (i)using commercially reasonable efforts to obtain the PIPE Investment and consummating the transactions contemplated by the PIPE Subscription Agreements; (j)exclusivity matters with respect to the Business Combination; (k)obtaining approval relating to Company Shares and Company Warrants for listing on Nasdaq; (l)delisting SPAC Units, shares of SPAC Class A Ordinary Shares and Public Warrants from Nasdaq; (m)executing Other Transaction Documents on the Closing Date; 149 (n)jointly preparing a press release which will have been agreed by each of the SPAC and the Company; and (o)consummating the transactions contemplated by the Backstop Agreement. Conditions to Closing Unless waived by the Company, SPAC and Merger Sub in writing, the obligations of the Company, SPAC and Merger Sub to consummate, or cause to be consummated, the Merger at Closing are subject to the satisfaction of the following conditions: •approval of the Business Combination and the Merger by the SPAC Shareholders; •the registration statement of which this proxy statement/prospectus is a part shall have become effective under the Securities Act, no stop order suspending the effectiveness of the registration statement shall be in effect, and no proceedings for that purpose shall have been initiated by the SEC and not withdrawn; •